Kings Path Partners’s LeMaitre Vascular LMAT Stock Holding History

Kings Path Partners’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$449K	Sell	4,675 -1,445	-24%	-$148K	0.12%	72
2026 Q1	$496K	Hold	6,120	–	–	0.17%	54
2025 Q4	$496K	Hold	6,120	–	–	0.17%	54
2025 Q3	$536K	Sell	6,120 -2,800	-31%	-$250K	0.2%	49
2025 Q2	$741K	Hold	8,920	–	–	0.3%	39
2025 Q1	$748K	Sell	8,920 -8,813	-50%	-$820K	0.37%	40
2024 Q4	$1.63M	Sell	17,733 -275	-2%	-$26.4K	0.7%	26
2024 Q3	$1.67M	Sell	18,008 -2,584	-13%	-$224K	0.7%	27
2024 Q2	$1.69M	Buy	+20,592	New	+$1.51M	0.8%	25

Other funds holding LMAT

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

LTAS

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

CCG

Chatham Capital Group Savannah, Georgia $783M AUM 31.99% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Kings Path Partners's LMAT Position: Q2 2026 in Review

Kings Path Partners reduced its LeMaitre Vascular (LMAT) stake by 24% in Q2 2026, selling an estimated $148K and leaving 4,675 shares worth $449K. The position accounts for 0.12% of the portfolio, ranked #72.

Kings Path Partners first reported a position in LMAT in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.69M in Q2 2024. 42 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Kings Path Partners held 4,675 shares of LeMaitre Vascular worth $449K as of Q2 2026.
Kings Path Partners sold 1,445 LeMaitre Vascular shares in Q2 2026, an estimated $148K.
LeMaitre Vascular made up 0.12% of Kings Path Partners's portfolio in Q2 2026, its #72 holding.
Kings Path Partners first reported a position in LeMaitre Vascular in Q2 2024 and has held it in 9 quarters since.
Kings Path Partners's LeMaitre Vascular position peaked at $1.69M in Q2 2024.
42 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Kings Path Partners's 13F filing for Q2 2026, filed 14 Jul 2026.